![Rachael Alford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Rachael Alford is Chief Operating Officer at Yarrow Bioscience, Inc. since 2026.
Formerly, Dr. Alford was Head-Chemistry, Manufacturing & Controls at Rallybio Corp.
from 2020 to 2026.
Education includes undergraduate and doctorate degrees from Imperial College London.
Postes actifs de Rachael Alford
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Rachael Alford
| Sociétés | Poste | Fin |
|---|---|---|
| RALLYBIO CORPORATION | Corporate Officer/Principal | 01/01/2026 |
Formation de Rachael Alford
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
